「完全主动脉修复」的中期结局:外科或腔内全主动脉弓置换联合胸腹分支/开窗腔内主动脉修复
单中心回顾2013至2022年480例接受医师改良或定制支架的胸腹分支/开窗腔内主动脉修复(FB-EVAR)患者,从中选取22例先行外科或腔内全主动脉弓置换/修复、再行远端FB-EVAR以处理累及升主动脉、弓部及胸腹主动脉(0-9区)的动脉瘤。早期无死亡,中期生存、免于二次干预及靶动脉稳定性尚可,作者认为分期「完全主动脉修复」安全有效。
要点
- 22例中无早期死亡,6例(27%)发生主要不良事件,4例(18%)发生脊髓损伤。
- Kaplan-Meier 3年患者生存率78±8%,免于二次干预56±11%,免于靶动脉不稳定68±11%。
- 作者认为分期外科或腔内全主动脉弓置换联合远端FB-EVAR安全有效,并发症可接受。
核心结论
- 作者认为,分期外科或腔内全主动脉弓置换/修复联合远端FB-EVAR的「完全主动脉修复」安全有效,发病率、中期生存及靶动脉结局令人满意。
研究设计与样本
- 单中心研究,回顾2013至2022年480例连续接受医师改良腔内移植物(PMEG)或定制支架行FB-EVAR的患者。
- 从中仅选取以开放或腔内弓部修复加远端FB-EVAR治疗累及升主动脉、弓部及胸腹主动脉段(0-9区)动脉瘤的患者。
- 定制器械在研究性器械豁免方案下使用;终点包括早期/院内死亡、中期生存、免于二次干预及靶动脉不稳定。
主要发现
- 共22例,男14例、女8例,中位年龄72±7岁;修复13例夹层后及9例退行性主动脉瘤,平均最大直径67±11 mm。
- 2期与3期修复策略自初次主动脉手术至动脉瘤隔绝的时间分别为169天和270天。
- 升主动脉及主动脉弓以19例外科和3例腔内全主动脉弓置换/修复处理;3例(16%)外科弓部手术在其他机构完成,围手术期资料不可获得。
- 平均体外循环、阻断及循环停跳时间分别为295±57、216±63、46±11分钟;2例患者共发生4次主要不良事件,均需术后血液透析,1例体外循环后心源性休克需体外膜氧合,另1例需清除慢性硬膜下血肿急性加重。
- 胸腹主动脉瘤修复使用17枚定制支架和5枚PMEG;无早期死亡,6例(27%)发生主要不良事件;4例(18%)脊髓损伤,其中3例(75%)出院前症状完全缓解。
临床怎么用
- 作者认为,在综合主动脉团队中,对最复杂的退行性和夹层后胸腹主动脉瘤行分期修复可安全实施,并发症情况与范围较小的修复相似。
- 作者认为,细致且有意识地进行病例规划对即刻和长期成功至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe a single-center experience of "complete aortic repair" consisting of surgical or endovascular total arch replacement/repair (TAR) followed by thoracoabdominal fenestrated-branched endovascular aortic repair (FB-EVAR). METHODS: We reviewed 480 consecutive patients who underwent FB-EVAR with physician-modified endografts (PMEGs) or manufactured stent-grafts between 2013 and 2022. From those, we selected only patients treated with open or endovascular arch repair and distal FB-EVAR for aneurysms involving the ascending, arch and thoracoabdominal aortic segments (zones 0-9). Manufactured devices were used under an investigational device exemption protocol. Endpoints included early/in-hospital mortality, mid-term survival, freedom from secondary intervention, and target artery instability. RESULTS: There were 22 patients, 14 men and 8 women with a median age of 72±7 years. Thirteen postdissection and 9 degenerative aortic aneurysms were repaired with a mean maximum diameter of 67±11 mm. Time from index aortic procedure to aneurysm exclusion was 169 and 270 days in those undergoing 2- and 3-stage repair strategies, respectively. The ascending aorta and aortic arch were treated with 19 surgical and 3 endovascular TAR procedures. Three (16%) surgical arch procedures were performed elsewhere, and perioperative details were unavailable. Mean bypass, cross-clamp, and circulatory arrest times were 295±57, 216±63, and 46±11 minutes, respectively. There were 4 major adverse events (MAEs) in 2 patients: both required postoperative hemodialysis, 1 had postbypass cardiogenic shock necessitating extracorporeal membrane oxygenation, and the other required evacuation of an acute-on-chronic subdural hematoma. Thoracoabdominal aortic aneurysm repair was performed with 17 manufactured endografts and 5 PMEGs. There was no early mortality. Six (27%) patients experienced MAEs. There were 4 (18%) cases of spinal cord injury with 3 (75%) experiencing complete symptom resolution before discharge. Mean follow-up was 30±17 months in which there were 5 patient deaths-0 aortic related. Eight patients required ≥1 secondary intervention, and 6 target arteries demonstrated instability (3 IC, 1 IIIC endoleaks; 2 TA stenoses). Kaplan-Meier 3-year estimates of patient survival, freedom from secondary intervention, and target artery instability were 78±8%, 56±11%, and 68±11%, respectively. CONCLUSION: Complete aortic repair with staged surgical or endovascular TAR and distal FB-EVAR is safe and effective with satisfactory morbidity, mid-term survival, and target artery outcomes.Clinical ImpactThe presented study demonstrates that repair of the entirety of the aorta - via total endovascular or hybrid means- is safe and effective with low rates of spinal cord ischemia. Cardiovascular specialists within comprehensive aortic teams at should feel confident that staged repair of the most complex degenerative and post-dissection thoracoabdominal aortic aneurysms can be safely performed in their patients with complication profile similar to that of less extensive repairs. Meticulous and intentional case planning is imperative for immediate and long-term success.
引用
- Chait J, Tenorio ER, Kawajiri H, et al. Mid-Term Outcomes of "Complete Aortic Repair": Surgical or Endovascular Total Arch Replacement With Thoracoabdominal Fenestrated-Branched Endovascular Aortic Repair. J Endovasc Ther. 2023. PMID: 37313951. doi:10.1177/15266028231181211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。